to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.
Preclinical characterization of mitochondria-targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancer.
Metastatic bone disease: role of transcription factors and future targets.
miRNA signatures associate with pathogenesis and progression of osteosarcoma.
Bookmarking target genes in mitosis: a shared epigenetic trait of phenotypic transcription factors and oncogenes?
MicroRNAs in the control of metastatic bone disease.
Runx2 is required for early stages of endochondral bone formation but delays final stages of bone repair in Axin2-deficient mice.
Runx2-Smad signaling impacts the progression of tumor-induced bone disease.
Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
A microRNA/Runx1/Runx2 network regulates prostate tumor progression from onset to adenocarcinoma in TRAMP mice.
Selective expression of long non-coding RNAs in a breast cancer cell progression model.
Intranuclear and higher-order chromatin organization of the major histone gene cluster in breast cancer.
Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention.